{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "April 2023: 58-year-old man presented with epigastric pain for 1 week. No significant medical or family history.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "58-year-old man presented with epigastric pain for 1 week.",
              "duration": "1 week",
              "onset": "April 2023",
              "progression": "unknown",
              "associated_symptoms": [
                "Epigastric pain"
              ]
            }
          ],
          "social_history": [
            {
              "category": "family history",
              "status": "negative",
              "description": "No significant family history"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Endoscopic ultrasonography revealed a 6-cm mass 25 cm into the esophagus from the incisors, invading the muscularis propria, with the thickest section measuring ~5.9 mm and the outer membrane remaining smooth, with two hypoechoic nodules in the mediastinum next to the lesioned esophagus.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Endoscopic ultrasonography",
              "body_part": "Esophagus",
              "modality": "Ultrasound",
              "finding": "6-cm mass 25 cm into the esophagus from the incisors, invading the muscularis propria, with the thickest section measuring ~5.9 mm and the outer membrane remaining smooth, with two hypoechoic nodules in the mediastinum next to the lesioned esophagus."
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Biopsy specimen H&E staining showed heterogeneous hyperplasia of the squamous epithelium with keratinized pearl formation, leading to a diagnosis of SCC.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0038454",
              "label": "Squamous Cell Carcinoma",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "Biopsy",
              "outcome": "Squamous Cell Carcinoma"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Pretreatment contrast-enhanced CT revealed thickening of the middle esophagus wall with mild uneven enhancement, and a homogeneously enhanced nodular shadow ~3mm in diameter on the left side of the lesion. No other metastatic foci observed in the abdominal CT and cranial magnetic resonance imaging.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Esophageal thickening",
              "body_part": "Esophagus",
              "modality": "CT",
              "finding": "thickening of the middle esophagus wall with mild uneven enhancement",
              "date": null
            },
            {
              "type": "Nodule",
              "body_part": "Esophagus",
              "modality": "CT",
              "finding": "homogeneously enhanced nodular shadow ~3mm in diameter on the left side of the lesion",
              "date": null
            },
            {
              "type": "Metastatic foci",
              "body_part": "Abdomen",
              "modality": "CT",
              "finding": "No other metastatic foci observed",
              "date": null
            },
            {
              "type": "Metastatic foci",
              "body_part": "Cranial",
              "modality": "MRI",
              "finding": "No other metastatic foci observed",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "The levels of neuron-specific enolase, carbohydrate antigen 19-9, carbohydrate antigen 125 and carcinoembryonic antigen were normal in the blood before treatment.",
        "clinical_data": {
          "labs": [
            {
              "test": "Neuron-specific enolase",
              "value": "normal",
              "unit": null,
              "flag": "normal"
            },
            {
              "test": "Carbohydrate Antigen 19-9",
              "value": "normal",
              "unit": null,
              "flag": "normal"
            },
            {
              "test": "Carbohydrate Antigen 125",
              "value": "normal",
              "unit": null,
              "flag": "normal"
            },
            {
              "test": "Carcinoembryonic antigen",
              "value": "normal",
              "unit": null,
              "flag": "normal"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient's pretreatment clinical stage was cT2N1M0, stage II.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0346958",
              "label": "Neoplasm Stage II",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "May 2023-June 2023: Patient underwent standard neoadjuvant immunochemotherapy, receiving 200 mg tislelizumab, an anti-programmed cell death protein 1 (PD-1) drug",
        "clinical_data": {
          "medications": [
            {
              "drug": "C4721528",
              "dosage": "200 mg",
              "frequency": "unknown",
              "modality": "IV",
              "start_date": "2023-05",
              "end_date": "2023-06",
              "indication": "Neoadjuvant therapy"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient's epigastric pain led to further investigation via endoscopic ultrasonography."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Mass identified via endoscopic ultrasonography was biopsied for further evaluation."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Diagnosis of SCC prompted pretreatment contrast-enhanced CT imaging."
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Pretreatment imaging was followed by blood tests to assess tumor markers."
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Lab results and imaging findings were used to determine the patient's clinical stage."
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Based on the patient's stage, neoadjuvant immunochemotherapy with tislelizumab was initiated.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C4721528"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2023-05-01T00:00:00Z"
        }
      }
    }
  ]
}